港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

1,298.537

-17.448-1.33%

漲家數：2

跌家數：15

平家數：1

市盈率：- -

高：1,321.833

開：1,316.231

低：1,290.254

收：1,315.985

成交量：3.63億

成交額：34.56億

市值：8,649.78億

流通市值：7,259.29億

資料載入中...

比亞迪召回超11萬輛汽車，1451億王傳福再迎新挑戰

謠言還是媒體瞎寫？比亞迪3.0發佈意味着什麼？

比亞迪電子盤中異動臨近午盤大幅跳水5.02%

京東健康-R盤中異動急速下跌4.24%

2025年前三季度國內汽車質量投訴指數分析

Ofweek光电信息网

港股異動 | 國藥控股(01099)漲超3% 本週將發三季度業績國藥股份第三季純利同比增長13.1%

疫苗賽道下一個「爆款」之爭

勁方醫藥-B(02595)：KRAS G12D抑制劑GFH375聯合西妥昔單抗或化療治療晚期實體瘤的Ib/II期研究完成首例患者給藥

中信建投 | 醫藥行業周度覆盤

中信建投证券研究

興業銀行助力復星高科成功發行全球首單民營企業玉蘭債

港股公告掘金 | 泡泡瑪特第三季度整體收益同比增長245%-250%

京東健康與廣藥集團達成戰略合作

一瓶美國藥，幾分中國料？

同源康醫藥-B(02410)：ESMO 2025年會公佈多項CDK抑制劑臨牀積極數據

京東健康聯合多家IVD品牌引領體外診斷院外化新趨勢

復星健康胡航：從灣區到東南亞，復星健康加速推進國際化戰略佈局

6億元！深圳產業基金投了這家張江企業

康希諾生物將再度參加CPHI展會期待攜手開拓國際市場

康希诺生物CanS...

甘肅農墾藥物鹼廠赴山東新華製藥參觀交流

海南礦業：上海復星高科技（集團）有限公司累計質押公司股份（含本次）7億股

每日经济新闻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=12"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":1298.5369,"timestamp":1761638912590,"preClose":1315.985,"halted":0,"volume":362625954,"delay":0,"changeRate":-0.013259,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-17.44812,"latestTime":"10-28 16:00:00","open":1316.2314,"high":1321.8334,"low":1290.2539,"amount":3456149233.8,"amplitude":0.023997,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1761787800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1761615000000,1761624000000],[1761627600000,1761638400000]],"pbRate":2.087397,"peRate":27.496762,"turnoverRate":0.004609,"increases":2,"decrements":15,"flats":0,"marketCap":864978357184,"floatMarketCap":725929441856},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1321.8334,"amplitude":0.023997,"preClose":1315.985,"low":1290.2539,"pbRate":"2.087397","latestPrice":1298.5369,"volume":362625954,"delay":0,"open":1316.2314,"prevYearClose":787.97723,"prevWeekClose":1302.542,"prevMonthClose":1449.838,"prevQuarterClose":1449.838,"fiveDayClose":1369.669,"twentyDayClose":1399.709,"sixtyDayClose":1205.049,"secType":"PLATE","market":"HK","turnoverRate":0.004609,"peRate":27.496762,"marketCap":864978357184,"floatMarketCap":725929441856,"timestamp":1761638912590,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":2,"down":15,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:12,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2577331829","title":"比亞迪召回超11萬輛汽車，1451億王傳福再迎新挑戰","url":"https://stock-news.laohu8.com/highlight/detail?id=2577331829","media":"砍柴网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577331829?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 12:30","pubTimestamp":1761107429,"startTime":"0","endTime":"0","summary":"比亚迪表示将免费为召回车辆进行更新、维修。“存在安全隐患”，比亚迪召回超11万辆汽车10月17日，国家市场监督管理总局官网发布重磅消息，比亚迪汽车工业有限公司根据《缺陷汽车产品召回管理条例》和《缺陷汽车产品召回管理条例实施办法》的要求，向国家市场监督管理总局备案了两项召回计划，共计召回车辆11.58万辆。根据官方公告，比亚迪此次召回分为两个批次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022123501a46da567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022123501a46da567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861214812.USD","LU0359201612.USD","LU1880383366.USD","LU0307460666.USD","LU1868837565.USD","LU1868837722.USD","SG9999015978.USD","BK1515","002594","SG9999001226.SGD","00285","LU0572944931.SGD","SG9999015945.SGD","LU1719994722.HKD","SG9999006597.SGD","LU0871576103.HKD","LU0259732245.USD","LU0516422440.USD","LU1303224171.USD","LU0229945570.USD","LU2476274720.SGD","81211","HYDD.SI","LU2249611893.SGD","LU0516423091.SGD","LU0511384066.AUD","LU2357125470.USD","SG9999014674.SGD","BK1610","LU0531971595.HKD","BYDDY","LU2348774022.SGD","LU1880383440.USD","LU0348767384.USD","LU0650527681.SGD","LU0359201885.HKD","LU0828238088.HKD","LU1861219969.SGD","LU0588545904.SGD","LU1794554557.SGD","LU1251922891.USD","LU0819121731.USD","01211","LU0449515922.USD","LU1770034418.SGD","LU2039709279.SGD","LU0516423174.USD","BK1582","LU0516422952.EUR","LU0593848301.USD"],"gpt_icon":1},{"id":"2577533997","title":"謠言還是媒體瞎寫？比亞迪3.0發佈意味着什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2577533997","media":"车乾信息","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577533997?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 12:01","pubTimestamp":1761105718,"startTime":"0","endTime":"0","summary":"综合有驾、懂车帝的新闻报道，比亚迪于10月15日发布了刀片电池3.0。刀片电池3.0的核心定位与真实性真实性：它是真实存在的，是比亚迪在2023年8月的“豹力全开 共赴山海”发布会上，随全新专业个性化品牌“方程豹”及其首款车型“豹5”一同亮相的最新电池技术。而比亚迪主供磷酸铁锂，目前宣传的文章说高镍材料体系，应该不是准确的信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022123012a46da3c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022123012a46da3c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1582","LU0164865239.USD","LU0143863198.USD","LU1794554557.SGD","BYDDY","SG9999002828.SGD","LU1719994722.HKD","LU1868837722.USD","LU0593848301.USD","LU1328277881.USD","SG9999015952.SGD","SG9999015945.SGD","LU0084288322.USD","002594","LU0823414551.USD","LU0634319403.HKD","LU1242518857.USD","SG9999001226.SGD","LU0274383008.USD","LU0314109678.HKD","BK1515","00285","LU0359201885.HKD","LU0540923850.HKD","LU0819121731.USD","LU0865486749.SGD","LU0165289439.USD","LU0823426308.USD","BK1540","LU0320764599.SGD","LU0348735423.USD","01211","LU0469268626.HKD","LU0819123356.HKD","SG9999015986.USD","HYDD.SI","81211","LU0348825331.USD","LU1813983027.USD","LU0463099449.HKD","LU0828238088.HKD","LU0175139822.USD","LU0871576103.HKD","LU0516422440.USD","BK1594","BK1504","LU0348827113.USD","LU2097828474.EUR","LU0043850808.USD","LU0417516738.SGD"],"gpt_icon":1},{"id":"2577335173","title":"比亞迪電子盤中異動 臨近午盤大幅跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577335173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577335173?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 11:36","pubTimestamp":1761104211,"startTime":"0","endTime":"0","summary":"2025年10月22日临近午盘11时36分，比亚迪电子股票出现波动，股价急速跳水5.02%。截至发稿，该股报38.200港元/股，成交量1145.81万股，换手率0.51%，振幅4.43%。比亚迪电子股票所在的消费性电讯设备行业中，整体跌幅为0.50%。其相关个股中，晨讯科技、ATLINKS、富智康集团涨幅较大，振幅较大的相关个股有鸿腾精密、比亚迪电子、晨讯科技，振幅分别为4.44%、4.43%、2.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022113651a6c70d47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022113651a6c70d47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1582","BK1580","BK1607","BK1515","00285","BK1540","BK1149","LU0348766576.USD","LU0274383008.USD","BK1504","BK1589","LU0348767384.USD"],"gpt_icon":0},{"id":"2577441317","title":"京東健康-R盤中異動 急速下跌4.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577441317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577441317?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 11:36","pubTimestamp":1761104175,"startTime":"0","endTime":"0","summary":"2025年10月22日临近午盘11时36分，京东健康-R股票出现异动，股价快速下挫4.24%。京东健康-R股票所在的药品分销行业中，整体跌幅为1.28%。其相关个股中，国药控股、叮当健康、新锐医药涨幅较大，振幅较大的相关个股有叮当健康、方舟健客、思派健康，振幅分别为6.48%、6.22%、5.60%。消息层面，截至11时36分，《京东健康与广药集团达成战略合作》资讯为影响京东健康-R的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022113615a6c70d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022113615a6c70d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","86618","BK1615","SGXZ86797644.SGD","BK1515","BK1583","SGXZ62798434.SGD","BK1247","LU0456827905.SGD","BK1591","06618","BK1142","LU0051755006.USD","BK1571"],"gpt_icon":0},{"id":"2577083333","title":"2025年前三季度國內汽車質量投訴指數分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2577083333","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577083333?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 11:10","pubTimestamp":1761102600,"startTime":"0","endTime":"0","summary":"日前，汽车门网发布了2025年前三季度汽车质量投诉指数。而且多个品牌今年前三季度再次因各自的老问题被集中投诉，进而投诉指数均不同幅度上涨。2025年前三季度车型投诉指数排行比亚迪整体投诉指数的“鹤立鸡群”也体现在了车型投诉榜上。2025年前三季度投诉指数车辆类型分布从涉诉车型看，今年前三季度，SUV依然是被投诉最多的两大车型，中型车紧随其后排名第二。若剔除这部分投诉，今年前三季度整体投诉指数基本与去年同期持平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111726a46d83d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111726a46d83d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0819123356.HKD","BK1607","LU0043850808.USD","LU1242518857.USD","LU0417516738.SGD","BK1149","LU0511384066.AUD","BYDDY","LU0594300419.USD","LU0561508036.HKD","LU2294711713.HKD","01211","HYDD.SI","BK1504","LU0143863784.USD","LU0259732245.USD","LU1868837565.USD","LU0605514214.HKD","LU0823414551.USD","81211","LU0594300179.USD","LU0505663152.USD","SG9999015986.USD","LU1328277881.USD","LU0164872284.USD","SG9999015978.USD","LU0823038988.USD","BK1515","LU0326950275.SGD","LU2476274308.USD","LU0348825331.USD","LU0823039010.USD","LU1813983027.USD","BK1539","LU0244354667.USD","LU0634319403.HKD","00285","LU0865486749.SGD","LU1303224171.USD","LU0593848301.USD","LU2097828474.EUR","LU1808992512.USD","LU0289960550.SGD","LU2449936058.SGD","02015","002594","LU0359201612.USD","SG9999015952.SGD","SG9999006597.SGD","LU2476274720.SGD","LU0211977185.USD"],"gpt_icon":1},{"id":"2577838707","title":"港股異動 | 國藥控股(01099)漲超3% 本週將發三季度業績 國藥股份第三季純利同比增長13.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577838707","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577838707?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 09:53","pubTimestamp":1761098035,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国药控股(01099)涨超3%，截至发稿，涨3.26%，报19.33港元，成交额7191.44万港元。消息面上，国药控股将于10月24日 (星期五)举行董事会会议，以考虑及批准(其中包括)公司及其附属公司截至2025年9月30日止九个月的未经审核季度业绩。该公司附属国药股份第三季度实现营业收入137.47亿元，同比增长3.58%；归属于上市公司股东的净利润为5.44亿元，同比增长13.10%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0097","BK1500","BK0012","01099","BK0188","BK1197","BK0185","BK1515","BK0175","LU0640798160.USD","LU1115378108.SGD","600511","BK0028","BK0010","BK0250","BK0082"],"gpt_icon":0},{"id":"2577339855","title":"疫苗賽道下一個「爆款」之爭","url":"https://stock-news.laohu8.com/highlight/detail?id=2577339855","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577339855?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 08:52","pubTimestamp":1761094350,"startTime":"0","endTime":"0","summary":"或许正是下一个“现象级”爆款诞生之日。由此不难看出，“五联苗”技术壁垒较高，能够为企业创造长期持续的稳定现金流，这也是其有望成为下一个爆款的原因。03 结语在疫苗赛道长期低迷的情况下，产业急需“五联苗”这样的爆款品类提振信心。当然这并不意味着康希诺将退出竞争，补上脊灰疫苗后康希诺依然具备后续跟进传统“五联苗”研发的能力，这场疫苗赛道下一个“爆款”之争依然存在较大变数。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102210015294d6cd22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102210015294d6cd22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1191","06185","BK1515"],"gpt_icon":0},{"id":"2577198386","title":"勁方醫藥-B(02595)：KRAS G12D抑制劑GFH375聯合西妥昔單抗或化療治療晚期實體瘤的Ib/II期研究完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2577198386","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577198386?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 07:34","pubTimestamp":1761089667,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B 发布公告，GFH375联合疗法治疗KRAS G12D突变型晚期实体瘤的Ib/II期研究首例患者在北京大学肿瘤医院完成入组。Ib期试验将首先在北京大学肿瘤医院等约15家中心开展，整体试验的主要研究目的为评估GFH375联合西妥昔单抗或化疗两项联合疗法在实体瘤患者中的安全性╱耐受性、疗效和药代动力学特征。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02595","09939","BK1574","159938","BK1515","BK1161"],"gpt_icon":1},{"id":"2577696387","title":"中信建投 | 醫藥行業周度覆盤","url":"https://stock-news.laohu8.com/highlight/detail?id=2577696387","media":"中信建投证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577696387?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 07:25","pubTimestamp":1761089141,"startTime":"0","endTime":"0","summary":"药店行业关注三季度业绩及门店转型；医药流通行业关注三季度业绩及回款情况。刘若飞：中信建投证券医药行业分析师，北京大学生物技术硕士，2017年加入中信建投证券研究发展部。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022073057a46d1782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022073057a46d1782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1191","09997","BK1222","BK1161","BK1100","09926","01276","09939","03692","BK1574","BK1583","BK1589","BK1515"],"gpt_icon":0},{"id":"2577383657","title":"興業銀行助力復星高科成功發行全球首單民營企業玉蘭債","url":"https://stock-news.laohu8.com/highlight/detail?id=2577383657","media":"吉林日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577383657?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 00:39","pubTimestamp":1761064746,"startTime":"0","endTime":"0","summary":"近日，兴业银行作为承销商及基石投资人助力上海复星高科技（集团）有限公司发行全球首单民营企业“玉兰债”，发行规模10亿元，期限3年。此次全球首单民营企业“玉兰债”发行，进一步拓展了“玉兰债”的服务边界，拓宽了民营企业融资渠道，有效降低民营企业融资成本。截至2025年9月末，兴业银行民营经济贷款余额超1.75万亿元；2025年前三季度承销民营企业债务融资工具近300亿元，其中科创债占比过半。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022003907a46cb933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022003907a46cb933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2577746488","title":"港股公告掘金 | 泡泡瑪特第三季度整體收益同比增長245%-250%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577746488","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577746488?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 23:00","pubTimestamp":1761058811,"startTime":"0","endTime":"0","summary":"【重大事项】广和通(00638)：每股发售价21.5港元 香港公开发售获550.99倍认购中国生物制药(01177)：库莫西利联合氟维司群一线治疗晚期乳腺癌III期研究数据在ESMO 2025公布德林控股(01709)拟折让约11.34%先旧后新配股 净筹约7.61亿港元新世界发展(00017)澄清媒体报导：未就永续及其它债务证券进行任何债务管理项目中国神华(01088)：九江二期4号机组通过16","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"328c11dc5612fbb78b465cba7c9d8814","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0359201612.USD","LU0588546209.SGD","09992","BK1224","BK1506","BK1521","LU2543165471.USD","BK1602","LU0531971595.HKD","LU0871576103.HKD","LU0327786744.USD","LU0593848301.USD","00728","LU1481107354.HKD","LU0572944931.SGD","LU0359202008.SGD","LU0823426480.USD","BK1601","SGXZ86797644.SGD","BK1133","LU0164880469.USD","BK1594","LU0499858438.USD","BK1545","LU0211977185.USD","IE00BZ08YS42.EUR","LU1770036033.HKD","BK1610","LU0348766576.USD","LU1023057109.AUD","BK1592","LU0348767384.USD","LU0345775950.USD","01164","01177","BK1524","IE0034224299.USD","BK1589","IE00BZ08YR35.GBP","LU0149721374.USD","00590","LU0611395673.USD","LU0345776255.USD","BK1178","BK1502","IE00BZ08YT58.USD","LU0039217434.USD","BK1515","LU0499858602.USD","BK1191"],"gpt_icon":1},{"id":"2577427875","title":"京東健康與廣藥集團達成戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2577427875","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577427875?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 21:27","pubTimestamp":1761053259,"startTime":"0","endTime":"0","summary":"人民财讯10月21日电，10月21日，京东健康与广药集团在广州签署战略合作协议。根据合作协议，京东健康将为广药集团提供全渠道销售与供应链一体化解决方案。双方将聚焦精准采购、智能库存管理与自动化补货等方面，共建更加敏捷、高效的供应链体系。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213540155280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["86618","BK1583","SGXZ62798434.SGD","BK1615","SGXZ86797644.SGD","BK1142","BK1247","BK1589","LU0051755006.USD","BK1515","LU0456827905.SGD","06618","BK1571","BK1591"],"gpt_icon":0},{"id":"2577538357","title":"一瓶美國藥，幾分中國料？","url":"https://stock-news.laohu8.com/highlight/detail?id=2577538357","media":"波士财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577538357?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 20:52","pubTimestamp":1761051126,"startTime":"0","endTime":"0","summary":"根据美国药典委员会的详细分析，在679种广泛使用的原料药中，至少有37%需要中国的关键起始材料。而印度作为另一个主要原料药生产国，其原料药进口的70%实际上也来自中国。这意味着美国即使转向印度供应商，仍难摆脱对中国的间接依赖。中国的进阶在中国巩固原料药主导地位的同时，中国药企正快速向创新药领域进军。美国药企曾将原料生产迁至中国，看中的是低成本与高效率；如今，中国本土研发的创新药数量已超越美国，跃居全球首位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021205641a6c5f30a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021205641a6c5f30a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","02359","BK1191","BK1515"],"gpt_icon":0},{"id":"2577820586","title":"同源康醫藥-B(02410)：ESMO 2025年會公佈多項CDK抑制劑臨牀積極數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2577820586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577820586?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 20:12","pubTimestamp":1761048747,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，公司董事会欣然宣布重点布局的细胞周期蛋白依赖性激酶抑制剂(CDKi)领域的三款药物TYK-00540 (CDK2/4i)、TY-2699a (CDK7i)和TY-302 (CDK4/6i)的早期临床研究结果以壁报形式在欧洲肿瘤内科学会年会上展示。ESMO 2025年会于当地时间2025年10月17-21日在德国柏林召开。作为全球肿瘤学领域最具影响力的学术盛会之一，ESMO年会吸引了众多学界顶尖专家学者，提供了共同探讨临床难题、分享前沿进展的舞台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","159938","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2577682455","title":"京東健康聯合多家IVD品牌 引領體外診斷院外化新趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2577682455","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577682455?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 19:10","pubTimestamp":1761045001,"startTime":"0","endTime":"0","summary":"本报讯（记者袁传玺）近日，京东健康联合万孚生物、雅培、可孚、英诺特、康华生物、可丽蓝等知名体外诊断品牌，发起“JDH+N”京东健康医疗器械IVD（体外诊断）品牌联盟。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213540076522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SGXZ62798434.SGD","LU0051755006.USD","BK1591","BK1589","BK1247","BK1515","SGXZ86797644.SGD","LU0456827905.SGD","BK1615","06618","BK1583","86618","BK1142","BK1571"],"gpt_icon":0},{"id":"2577238365","title":"復星健康胡航：從灣區到東南亞，復星健康加速推進國際化戰略佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2577238365","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577238365?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 18:41","pubTimestamp":1761043260,"startTime":"0","endTime":"0","summary":"10月20日，香港英文媒体《South China Morning Post》刊登了对复星健康董事长兼CEO胡航的专访，解读了复星健康国际化战略布局。胡航表示，复星健康已将业务拓展目光聚焦于南亚、东南亚及中东地区日益增长的医疗旅游客群，正积极把握当地经济增长与医疗体系分散所带来的机遇，计划稳步拓展市场。复星健康作为复星医药旗下成员企业，在中国大陆营运19家医疗机构，其中四家位于粤港澳大湾区。胡航称，国际医疗市场存在大量未满足需求，复星健康致力于为本地无法获得完整治疗方案的患者提供医疗新选择。目前亚洲医疗旅游市场以新加坡和泰国为主导，复星健康正积极布局，将粤港澳大湾区作为战略发展核心区域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021190517a6c5c43e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021190517a6c5c43e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","BK1191","02196"],"gpt_icon":0},{"id":"2577113822","title":"6億元！深圳產業基金投了這家張江企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2577113822","media":"张通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577113822?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 18:24","pubTimestamp":1761042240,"startTime":"0","endTime":"0","summary":"同时，复星医药若干董事、高管还兼任深圳生物医药产业基金投委会成员，因此深圳生物医药产业基金也构成复星医药的关联方。复星医药产业的持股比例将从88.14%降至69.50%，深圳生物医药产业基金将持股21.03%，成为继复星医药产业之后的第二大股东。此外，复星凯瑞董事会在本次增资完成后将由7位董事组成，其中：复星医药产业有权提名6名，深圳生物医药产业基金有权提名1名；坪山区引导基金有权委派1位董事会观察员。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-10-21/doc-infusekq9808801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02196","BK1593","BK1515"],"gpt_icon":0},{"id":"2577880568","title":"康希諾生物將再度參加CPHI展會 期待攜手開拓國際市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2577880568","media":"康希诺生物CanS...","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577880568?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 18:19","pubTimestamp":1761041964,"startTime":"0","endTime":"0","summary":"作为全球领先的创新疫苗企业，康希诺生物将携自主研发的丰富产品线参会，全方位呈现在创新肺炎疫苗、脑膜炎疫苗及组分百白破联合疫苗等关键领域的突出优势和深厚积累，并开启在全球疫苗CRDMO领域的创新合作与业务拓展。期待与世界制药行业的先锋力量共聚一堂，展开深度对话与战略合作，融通优质资源，携手开拓国际市场。关于康希诺生物康希诺生物股份公司，2009年成立于中国，致力于在世界范围内提供预防和治疗感染类疾病的解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021183723a6c5b76d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021183723a6c5b76d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1161","BK1515","BK1574","06185"],"gpt_icon":0},{"id":"2577307753","title":"甘肅農墾藥物鹼廠赴山東新華製藥參觀交流","url":"https://stock-news.laohu8.com/highlight/detail?id=2577307753","media":"甘肃农垦","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577307753?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 17:54","pubTimestamp":1761040484,"startTime":"0","endTime":"0","summary":"近日，药物碱厂党委书记、董事长刘杰率业务团队前往山东新华制药股份有限公司进行参观交流，就麻药产品联合开发、甘草浸膏供应服务及人员交流学习等多方面合作事宜展开深入洽谈。山东新华制药党委书记、董事长贺同庆陪同参观并参与座谈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021192636a46c4573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021192636a46c4573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","00719"],"gpt_icon":0},{"id":"2577383651","title":"海南礦業：上海復星高科技（集團）有限公司累計質押公司股份（含本次）7億股","url":"https://stock-news.laohu8.com/highlight/detail?id=2577383651","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577383651?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 17:44","pubTimestamp":1761039897,"startTime":"0","endTime":"0","summary":"每经AI快讯，海南矿业10月21日晚间发布公告称，截至本公告日，海南矿业股份有限公司控股股东上海复星高科技（集团）有限公司持有公司股份约9.49亿股，占公司股份总数的47.49%；本次解除质押并再质押后，累计质押公司股份（含本次）7亿股，占其所持公司股份数的73.76%，占公司股份总数的35.03%。每经头条（nbdtoutiao）——展望“十五五”|专访贺铿：必须改变以往将资金过度集中于房屋建设和基础设施建设的倾向，更加突出民生领域投入（记者 王瀚黎）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021175111a46c1b0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021175111a46c1b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","BK1593","02196","00656"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":12,"totalSize":416,"code":"91000000","status":"200"}]}}